Lithium Carbonate

Dosage for Lithium Carbonate must be highly individualized based on the patient's clinical response and serum lithium levels. There is no 'one-size-fits-all' dose.

• Acute Mania: For adults experiencing an acute manic episode, the typical starting dose is 600 mg to 900 mg per day, divided into two or three doses. This is often increased rapidly to 1,800 mg per day to achieve a therapeutic serum level between 1.0 and 1.5 mEq/L.
• Maintenance Therapy: For long-term stabilization, the target serum level is generally lower, ranging from 0.6 to 1.2 mEq/L. This usually requires a total daily dose of 900 mg to 1,200 mg, divided into two or three doses.

Healthcare providers will typically check blood levels 8 to 12 hours after the last dose (trough level) to ensure the medication is within the therapeutic window.

Lithium Carbonate is FDA-approved for the treatment of Bipolar Disorder in children and adolescents aged 7 years and older.

• Children (7-17 years): Dosing is usually based on weight and clinical response. For children under 30 kg, starting doses may be as low as 300 mg twice daily. For those over 30 kg, the starting dose is often 300 mg three times daily. The goal is to maintain the same therapeutic serum levels as adults (0.6 to 1.2 mEq/L). Close monitoring of renal and thyroid function is even more critical in pediatric populations due to the potential impact on growth and development.

Renal Impairment

Since Lithium is cleared almost exclusively by the kidneys, any degree of renal impairment requires significant dose reductions. In patients with mild to moderate kidney disease, the dose may be reduced by 25% to 50%. Lithium is generally contraindicated in patients with severe renal failure or acute kidney injury.

Hepatic Impairment

Because Lithium is not metabolized by the liver, no dosage adjustments are typically required for patients with liver disease. However, these patients should still be monitored for overall fluid and electrolyte balance.

Elderly Patients

Older adults often have reduced kidney function even if their serum creatinine levels appear normal. They are also more sensitive to the neurological side effects of Lithium. Healthcare providers usually start elderly patients on very low doses (e.g., 150 mg to 300 mg daily) and titrate slowly, aiming for a lower therapeutic range of 0.4 to 0.8 mEq/L.

To ensure the safety and efficacy of Lithium Carbonate, follow these specific instructions:

• Consistency is Key: Take your medication at the same time every day to maintain stable blood levels.
• With Food: Lithium can cause significant stomach upset. Taking it with a meal or a glass of milk can help mitigate nausea and abdominal pain.
• Hydration: You must maintain a steady intake of fluids (8-12 glasses of water a day). Dehydration can lead to toxic lithium levels.
• Salt Intake: Do not make sudden changes to the amount of salt in your diet. A sudden decrease in salt can cause lithium levels to rise, while a sudden increase can cause them to drop.
• Swallow Whole: If you are taking extended-release tablets (Lithobid or Eskalith CR), do not crush, chew, or break them, as this will release the entire dose at once and increase the risk of toxicity.

If you miss a dose of Lithium Carbonate, take it as soon as you remember. However, if it is within a few hours of your next scheduled dose, skip the missed dose and return to your regular schedule. Never double the dose to catch up, as this can push your blood levels into the toxic range.

Lithium overdose is a medical emergency. Signs of toxicity include:

• Severe nausea, vomiting, and diarrhea
• Extreme drowsiness and muscle weakness
• Lack of coordination (ataxia)
• Blurred vision and ringing in the ears (tinnitus)
• Large amounts of dilute urine
• Seizures or coma in severe cases

If an overdose is suspected, contact emergency services or a poison control center immediately. Treatment often involves gastric lavage (stomach pumping), intravenous fluids to restore electrolyte balance, and in severe cases, hemodialysis (filtering the blood) to remove the lithium.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this can lead to a rapid relapse of symptoms.

Many patients experience side effects when starting Lithium Carbonate, though many of these diminish as the body adjusts to the medication. Common experiences include:

• Hand Tremor: A fine, rhythmic shaking of the hands is very common. It is usually most noticeable when performing fine motor tasks like writing or holding a cup.
• Polyuria and Polydipsia: Increased urination and excessive thirst occur because lithium affects the kidneys' ability to concentrate urine. Patients may find themselves drinking significantly more water than usual.
• Gastrointestinal Distress: Mild nausea, stomach pain, and diarrhea are frequent, especially during the first few weeks of treatment.
• Weight Gain: Many patients experience a gradual increase in weight, which may be due to metabolic changes or increased consumption of high-calorie beverages to satisfy thirst.
• Cognitive 'Fog': Some patients report feeling mentally slowed down, having difficulty concentrating, or experiencing a 'dulled' emotional state.

• Dermatological Issues: Lithium can exacerbate acne or psoriasis. Some patients may develop a rash or thinning of the hair (alopecia).
• Muscle Weakness: A general feeling of fatigue or lack of strength in the limbs.
• Edema: Swelling in the ankles or fingers due to fluid retention.
• Metallic Taste: A persistent metallic or 'funny' taste in the mouth.

• Brugada Syndrome Unmasking: Lithium can occasionally reveal an underlying heart rhythm disorder called Brugada syndrome, which can be dangerous.
• Pseudotumor Cerebri: Increased pressure within the skull that can cause headaches and vision changes.
• Hyperparathyroidism: Lithium can cause the parathyroid glands to overproduce hormones, leading to high calcium levels in the blood (hypercalcemia).

> Warning: Stop taking Lithium Carbonate and call your doctor immediately if you experience any of these serious symptoms:

• Lithium Toxicity Symptoms: If you experience severe tremors, slurred speech, confusion, or extreme dizziness, your lithium levels may be too high.
• Serotonin Syndrome: If taken with other serotonergic drugs, you may experience agitation, hallucinations, rapid heart rate, and muscle stiffness.
• Severe Allergic Reaction: Symptoms include hives, difficulty breathing, or swelling of the face, lips, and throat (anaphylaxis).
• Vision Changes: Sudden blurring or loss of vision.
• Cardiac Arrhythmia: Feeling like your heart is skipping beats, fluttering, or beating too hard.

Lithium Carbonate is often taken for years, which necessitates monitoring for long-term complications:

• Hypothyroidism: Lithium interferes with the synthesis and release of thyroid hormones. Up to 10-20% of long-term users may develop an underactive thyroid, requiring thyroid hormone replacement (levothyroxine).
• Chronic Kidney Disease (CKD): Prolonged use can lead to structural changes in the kidneys, such as interstitial fibrosis. This is why regular monitoring of the Glomerular Filtration Rate (GFR) and creatinine levels is essential.
• Nephrogenic Diabetes Insipidus (NDI): This is a condition where the kidneys become resistant to the antidiuretic hormone, leading to the production of massive amounts of dilute urine.
• Hypercalcemia: Long-term lithium use is associated with elevated calcium levels, which can contribute to kidney stones or bone thinning (osteoporosis).

Lithium Carbonate carries a significant FDA Black Box Warning regarding Lithium Toxicity:

Summary of Warning: Lithium toxicity is closely related to serum lithium levels and can occur at doses close to therapeutic levels. Facilities for prompt and accurate serum lithium determinations should be available before initiating therapy. Toxicity can lead to permanent neurological damage or death. Patients must be educated on the signs of toxicity and the importance of maintaining adequate salt and water intake. Healthcare providers must monitor levels frequently during the initial titration and periodically during maintenance.

Report any unusual symptoms to your healthcare provider immediately. Regular laboratory monitoring is the best way to prevent these side effects from becoming serious health issues.

Lithium Carbonate is a high-alert medication. Its safety depends entirely on maintaining a precise concentration in the bloodstream. Patients must be committed to regular blood draws and must have a clear understanding of the factors that can change lithium levels, such as diet, hydration, and other medications.

Lithium Toxicity: The FDA mandates a black box warning for Lithium Carbonate because the margin between a safe dose and a toxic dose is very narrow. Toxicity can occur even when the dose seems appropriate if the patient becomes dehydrated, changes their salt intake, or takes certain other medications. Severe toxicity can result in seizures, coma, and irreversible brain damage. Monitoring serum lithium levels is not optional; it is a clinical requirement for safe use.

• Allergic Reactions: While rare, hypersensitivity to lithium or the inactive ingredients in the tablets can occur. If you develop a fever, swollen lymph nodes, or a severe skin rash, seek medical help.
• Renal Toxicity: Chronic lithium therapy can cause 'nephrogenic diabetes insipidus' and chronic interstitial nephritis. Patients with pre-existing kidney disease must use lithium with extreme caution, if at all.
• Cardiovascular Risk: Lithium can cause EKG changes, including T-wave flattening and sinus node dysfunction. It should be used cautiously in patients with known heart disease.
• Encephalopathic Syndrome: In rare cases, especially when combined with antipsychotics (like haloperidol), lithium has been associated with a severe brain syndrome characterized by weakness, fever, tremulousness, and confusion.
• Hypothyroidism: Because lithium inhibits thyroid hormone release, patients may develop goiter (enlarged thyroid) or hypothyroidism. This is usually reversible upon discontinuation or manageable with thyroid medication.

To ensure safety, your healthcare provider will order the following tests:

• Serum Lithium Levels: Initially every few days, then every 1-3 months once stable. Samples should be drawn 12 hours after the last dose.
• Renal Function Tests: Serum creatinine and BUN (Blood Urea Nitrogen) should be checked every 3 to 6 months to monitor kidney health.
• Thyroid Function Tests (TSH): Checked before starting and every 6 to 12 months thereafter.
• Electrolytes: Specifically sodium and calcium levels.
• Weight and BMI: To monitor for metabolic changes.

Lithium Carbonate can cause drowsiness, dizziness, and blurred vision, especially when first starting the medication or when increasing the dose. Do not drive or operate heavy machinery until you know how Lithium affects you. If you feel 'foggy' or uncoordinated, avoid activities that require high mental alertness.

Alcohol should be avoided or strictly limited while taking Lithium Carbonate. Alcohol is a diuretic (increases urination), which can lead to dehydration. Dehydration causes the kidneys to retain lithium, potentially leading to toxicity. Furthermore, alcohol can worsen the cognitive side effects and mood instability that Lithium is intended to treat.

Never stop taking Lithium Carbonate abruptly. Sudden discontinuation is associated with a very high risk of immediate relapse into a manic or depressive state. If the medication must be stopped, your healthcare provider will guide you through a slow tapering process over several weeks or months to allow your brain chemistry to adjust.

> Important: Discuss all your medical conditions, especially kidney, heart, or thyroid problems, with your healthcare provider before starting Lithium Carbonate.

Certain medications should never be combined with Lithium Carbonate due to the extreme risk of toxicity or severe adverse events:

• Thiazide Diuretics (e.g., Hydrochlorothiazide): These drugs cause the kidneys to excrete sodium while retaining lithium. This can rapidly double or triple lithium levels, leading to life-threatening toxicity.
• Certain Antipsychotics (High-Dose Haloperidol): While often combined safely, high doses of both have been linked to an irreversible 'encephalopathic syndrome' characterized by brain damage.

• NSAIDs (Nonsteroidal Anti-inflammatory Drugs): Common over-the-counter painkillers like Ibuprofen (Advil, Motrin) and Naproxen (Aleve) can reduce lithium clearance by the kidneys, increasing lithium levels by up to 40%. Aspirin is generally considered a safer alternative for pain.
• ACE Inhibitors and ARBs: Medications for high blood pressure like Lisinopril or Losartan can significantly increase lithium concentrations. If these must be used, lithium doses usually need to be lowered.
• Loop Diuretics (e.g., Furosemide): While less dangerous than thiazides, they still pose a risk of dehydration and lithium retention.
• SSRIs and SNRIs: Combining lithium with antidepressants (like Fluoxetine or Venlafaxine) increases the risk of Serotonin Syndrome, a potentially fatal condition caused by too much serotonin in the brain.

• Calcium Channel Blockers (e.g., Verapamil, Diltiazem): These can increase the neurotoxicity of lithium even if blood levels remain in the normal range.
• Theophylline and Caffeine: These substances can actually increase the excretion of lithium, making the medication less effective. If you suddenly stop drinking coffee, your lithium levels may rise.
• Sodium Bicarbonate: Large amounts of sodium can lower lithium levels.

• Sodium (Salt): This is the most critical dietary interaction. Lithium and sodium are handled similarly by the kidneys. If you go on a low-salt diet, your kidneys will hold onto lithium instead of salt, causing toxicity. Conversely, a very high-salt diet will cause your kidneys to flush out lithium, leading to a relapse of bipolar symptoms.
• Hydration: Caffeine and alcohol act as diuretics and should be used with caution. Maintain a consistent intake of water throughout the day.

• St. John’s Wort: Increases the risk of serotonin syndrome.
• Psyllium (Fiber Supplements): May interfere with the absorption of lithium if taken at the same time.
• Diuretic Herbs: Herbs like dandelion or juniper can cause dehydration and increase lithium levels.

Lithium Carbonate can interfere with certain laboratory results:

• White Blood Cell Count (WBC): Lithium often causes a harmless increase in WBCs (leukocytosis).
• Blood Glucose: Lithium may affect glucose metabolism, potentially altering blood sugar readings in diabetic patients.
• Thyroid Panels: Lithium frequently causes an increase in TSH (Thyroid Stimulating Hormone).

For each major interaction, the mechanism usually involves the kidneys' proximal tubules. Because the body sees lithium as 'salt,' anything that makes the body crave salt (dehydration, low-salt diet, certain blood pressure meds) will make the body keep lithium. The management strategy is always the same: frequent blood monitoring and dose adjustment by a professional.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter painkillers.

Lithium Carbonate must NEVER be used in the following circumstances:

• Severe Renal Disease: If the kidneys cannot filter waste effectively (e.g., end-stage renal disease), lithium will accumulate rapidly to lethal levels. The mechanism is a complete lack of drug clearance.
• Severe Cardiovascular Disease: Lithium can interfere with the heart's electrical conduction. In patients with significant heart failure or unstable arrhythmias, the risk of cardiac arrest is too high.
• Severe Dehydration or Sodium Depletion: Patients who are severely dehydrated or on a salt-restricted diet are at immediate risk of lithium toxicity because the kidneys will prioritize reabsorbing lithium over excreting it.
• Hypersensitivity: Any known severe allergy to lithium salts or any component of the formulation.

These conditions require a careful risk-benefit analysis by a specialist:

• Mild to Moderate Renal Impairment: Requires very frequent monitoring and lower-than-normal doses.
• Thyroid Disease: Pre-existing hypothyroidism can be worsened by lithium, though it can often be managed by adding thyroid hormone replacement.
• Pregnancy (First Trimester): Lithium is associated with a specific heart defect in the fetus (Ebstein's Anomaly). However, if the mother's bipolar disorder is life-threatening, the doctor may decide the benefit outweighs the risk.
• Epilepsy: Lithium can lower the seizure threshold in some patients, though it is not an absolute contraindication.
• Psoriasis: Lithium often causes severe flare-ups of psoriasis, which may make the drug intolerable for some patients.

There is no significant cross-sensitivity between Lithium Carbonate and other classes of psychiatric medications (like antipsychotics or antidepressants). However, patients who have had a 'neuroleptic malignant syndrome' (NMS) from antipsychotics should be monitored closely when starting lithium, as the symptoms of lithium toxicity can sometimes mimic NMS.

> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and heart health, before prescribing Lithium Carbonate.

Lithium Carbonate is classified as FDA Pregnancy Category D, meaning there is positive evidence of human fetal risk based on adverse reaction data.

• First Trimester: Exposure during the first 12 weeks of pregnancy is linked to a rare cardiac malformation known as Ebstein’s Anomaly (a defect of the tricuspid valve). While the absolute risk is lower than previously thought (approximately 1 in 1,000 to 1 in 600), it is significantly higher than the general population.
• Later Pregnancy: Lithium can cause 'Floppy Baby Syndrome' (hypotonia), cyanosis, and thyroid dysfunction in the newborn if taken near delivery.
• Management: If a patient becomes pregnant, the dose must be monitored very closely because kidney function increases during pregnancy, often requiring higher doses, which must then be rapidly decreased immediately after delivery to avoid toxicity.

Lithium is excreted in human breast milk at concentrations approximately 40% to 50% of the mother's serum level. This can cause lithium toxicity in the nursing infant, characterized by lethargy, cyanosis, and poor feeding. Most clinical guidelines recommend avoiding breastfeeding while taking Lithium Carbonate unless the benefits clearly outweigh the risks and the infant's blood levels can be monitored.

Lithium is approved for Bipolar Disorder in children aged 7 and older. It is not recommended for children under 7 due to a lack of safety data. In pediatric patients, lithium can affect bone metabolism and thyroid function. Long-term studies on the impact of lithium on the developing brain and growth are ongoing, so pediatric use must be managed by a child psychiatrist.

Elderly patients (65+) are at a much higher risk for lithium toxicity.

• Reduced Clearance: Natural age-related decline in kidney function means lithium stays in the body longer.
• Sensitivity: The aging brain is more sensitive to the neurological side effects, such as confusion and tremors.
• Polypharmacy: Older adults are more likely to be taking interacting medications like blood pressure pills or NSAIDs for arthritis.
• Fall Risk: The dizziness and lack of coordination caused by lithium can increase the risk of dangerous falls and fractures.

Patients with a GFR (Glomerular Filtration Rate) below 60 mL/min require extreme caution. Lithium is generally avoided if GFR is below 30 mL/min. For those on hemodialysis, lithium is sometimes given as a single dose after each dialysis session, as dialysis effectively removes lithium from the blood.

No specific adjustments are needed for liver disease (Child-Pugh A, B, or C) because the liver does not process lithium. However, these patients often have fluid balance issues (like ascites) which can indirectly affect lithium levels.

> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring than the general population.

Lithium Carbonate's molecular mechanism is multifaceted. Unlike most drugs that bind to a specific receptor (like a lock and key), Lithium acts as a systemic modulator.

1. 1GSK-3 Inhibition: Lithium directly inhibits Glycogen Synthase Kinase-3, an enzyme that regulates cell survival and synaptic plasticity. By inhibiting GSK-3, lithium increases the levels of beta-catenin, which promotes neuroprotective pathways.
2. 2Inositol Depletion: It inhibits inositol monophosphatase (IMPase). This reduces the recycling of inositol, which is necessary for the production of second messengers (IP3 and DAG) that are overactive in manic states.
3. 3Neurotransmission: It decreases the activity of excitatory neurotransmitters (glutamate and dopamine) while enhancing the activity of inhibitory neurotransmitters (GABA).

Lithium has a slow onset of action. While some effects on sleep and agitation may be seen within days, the full antimanic effect usually takes 1 to 2 weeks. The full antidepressant or prophylactic (preventative) effect may take several months of consistent use. Tolerance to the mood-stabilizing effects does not typically develop, making it suitable for decades of use.

| Parameter | Value |

|---|---|

| Bioavailability | 95% - 100% |

| Protein Binding | 0% |

| Half-life | 18 - 36 hours (Adults); up to 36+ (Elderly) |

| Tmax (Immediate Release) | 1 - 3 hours |

| Tmax (Extended Release) | 4 - 12 hours |

| Metabolism | None (Not metabolized) |

| Excretion | Renal (95%); Sweat/Fecal (<5%) |

• Molecular Formula: Li2CO3
• Molecular Weight: 73.89 g/mol
• Solubility: Slightly soluble in water; solubility decreases as temperature increases.
• Structure: It is an inorganic salt consisting of two lithium cations and one carbonate anion. It appears as a white, odorless crystalline powder.

Lithium Carbonate is the primary member of the Antimanic Agents class. While other drugs like Valproate or Quetiapine are used as mood stabilizers, Lithium is unique because it is a simple ion rather than a complex organic molecule. It is often grouped with 'Mood Stabilizers' in clinical practice.